Today: 30 April 2026
Intuitive Machines (LUNR) stock drops 7% after $800 million Lanteris deal closes, filings in focus
13 January 2026
2 mins read

Intuitive Machines (LUNR) stock drops 7% after $800 million Lanteris deal closes, filings in focus

New York, January 13, 2026, 15:38 (EST) — Regular session

  • Shares of Intuitive Machines dropped roughly 7% in afternoon trading following the completion of its Lanteris acquisition
  • The SEC filing outlined the cash-and-stock terms, along with financing and registration rights linked to the deal
  • Investors await updated financial disclosures and the company’s next earnings report in March

Intuitive Machines shares dropped roughly 7% to $17.85 Tuesday afternoon following the completion of its much-anticipated acquisition of satellite maker Lanteris Space Systems. The stock fell as low as $17.21 after starting the day around $19.31.

This deal marks a turning point for Intuitive Machines, which gained recognition in public markets mainly through its lunar missions. It comes at a time when investors are swift to factor in dilution, funding requirements, and potential new debt-like liabilities at smaller space companies.

Intuitive Machines announced its acquisition of Lanteris, previously known as Maxar Space Systems, boosting its capabilities to deliver end-to-end services spanning low Earth orbit, medium Earth orbit, geostationary orbit, and cislunar space—the zone between Earth and the Moon. CEO Steve Altemus said, “With Lanteris, we add flight-proven manufacturing at scale.” Securities and Exchange Commission

A recent filing revealed the company paid about $403 million in cash and issued 22,991,028 Class A shares as stock consideration, valued around $284 million at a $12.34 per share estimate. The seller also secured registration rights, including the option to launch up to three underwritten public offerings. Additionally, a separate receivables facility linked to Lanteris allows purchases of certain customer payment streams up to $250 million through Dec. 1, 2026, according to the filing.

The deal, initially revealed in November, was valued at $800 million in a mix of cash and stock. Intuitive Machines projected that the merged entity would generate over $850 million in yearly revenue, backed by $920 million in contracts lined up through Sept. 30.

Some investors see Intuitive Machines not just as a lunar lander play but as a government-services contractor with steady, long-term projects. “Intuitive Machines’ primary source of revenue is not from its launch missions, but rather from its space contracts,” Cantor Fitzgerald analyst Andres Sheppard said in March, following the company’s earnings report and contract update. Reuters

Still, the market hasn’t forgotten execution risks with lunar hardware. Intuitive Machines’ initial two landers toppled onto their sides upon touchdown, which curtailed some mission objectives. The company has acknowledged that its wider growth strategy depends significantly on service contracts as well as flight operations.

With the Lanteris acquisition, Intuitive Machines steps deeper into a crowded, more seasoned segment of the space supply chain: crafting spacecraft and satellite platforms for national security, civil, and commercial clients. This move puts the company in direct competition with heavyweight U.S. aerospace and defense firms like Lockheed Martin and Northrop Grumman, which already dominate the market with satellite buses and space systems at scale.

The downside risk is clear-cut: hiccups in integration, slow contract awards, or cash needs exceeding forecasts might push the company to seek additional financing. Plus, the fresh registration rights could weigh on the stock if the seller opts to unload shares.

Traders will be focused on Intuitive Machines’ upcoming quarterly report, looking for fresh details on deal economics and how the company plans to deploy cash. The next update is due March 24, per Zacks.

Stock Market Today

  • Sensex Drops Over 800 Points Amid Rising Oil Prices and Foreign Investor Selling
    April 30, 2026, 12:47 AM EDT. The BSE Sensex fell 855.79 points (1.10%) to 76,640.57, while the Nifty 50 dropped 1.14%, pressured by a surge in crude oil prices above $120 per barrel. Higher oil costs raise inflation risks and widen India's current account deficit, dampening investor sentiment. Foreign institutional investors sold shares worth Rs 2,468 crore, while domestic investors bought Rs 2,262 crore. The rupee weakened past 95 against the US dollar, raising import costs and inflation worries. Global factors include a hawkish US Federal Reserve stance with stable interest rates but rising bond yields, attracting capital outflows from emerging markets. Sectoral declines were widespread, with Nifty Auto down 1.94%, Financial Services 1.25%, and PSU Bank 1.64%. Market volatility rose, reflected by a 4.55% increase in India VIX to 18.23.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 30.04.2026

30 April 2026
OCBC will pay a total dividend of S$0.58 per share in May, including a S$0.16 special dividend. UOB declared a final dividend of S$0.71 per share despite lower net interest income. ST Engineering reported higher revenue and profit, with a S$0.23 per share dividend. Jardine Matheson raised its annual dividend 4% to US$2.35 per share, payable mid-May.
Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus
Previous Story

Pfizer stock slips as CEO likens obesity drugs to Viagra; Metsera trials and Feb. 3 earnings in focus

Apple stock slips after-hours as Creator Studio launch and Google Gemini tie-up reset the AI pitch
Next Story

Apple stock slips after-hours as Creator Studio launch and Google Gemini tie-up reset the AI pitch

Go toTop